Abstract
The main characteristic of infections caused by mycobacteria is the presence of tuberculoid granuloma with chronic clinical evolution. Mycobacterioses can be divided into three groups of diseases: tuberculosis, leprosy, and non-tuberculous mycobacterioses (NTM). Cutaneous involvement by tuberculosis (Mycobacterium tuberculosis) is uncommon in both immunocompetent and immunosuppressed individuals. Hypersensitivity tuberculous reactions are rare in this population, as they are individuals undergoing chronic immunosuppression. Especially in endemic countries, leprosy (Mycobacterium leprae) can affect solid organ transplant recipients (SOTRs). An interesting aspect concerning leprosy is an inflammatory response decrease and leprosy reaction. Regarding NTM, SOTR is quite susceptible, both to mycobacteria that affect the skin and those that affect internal organs. SOTRs are frequently submitted to invasive procedures, so they are susceptible to mycobacteria cutaneous implantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO. Global tuberculosis report 2020. Available: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf.
Chen Q, Chen W, Hao F. Cutaneous tuberculosis: a great imitator. Clin Dermatol. 2019;37:192–9.
Ahmad S. New approaches in the diagnosis and treatment of a latent tuberculosis infection. Respir Res. 2010;11(1):169.
Körner MM, Hirata N, Tenderich G, Minami K, Mannebach H, Kleesiek K, et al. Tuberculosis in heart transplant recipients. Chest. 1997;111(2):365–9.
Lattes R, Radisic M, Rial M, Argento J, Casadei D. Tuberculosis in renal transplant recipients. Transpl Infect Dis. 1999;1(2):98–104.
Ersan S, Celik A, Atila K, Sifil AA, Cavdar C, Soylu A, et al. Ren Fail. 2011;33(8):753–7.
Mamishi S, Pourakbari B, Moradzadeh M, van Leeuwen WB, Mahmoudi S. Prevalence of active tuberculosis infection in transplant recipients: a systematic review and meta-analysis. Microb Pathog. 2020;139:103894. https://doi.org/10.1016/j.micpath.2019.103894.
Dias MF, Bernardes Filho F, Quaresma MV, Nascimento LV, Nery JA, Azulay DR. Update on cutaneous tuberculosis. An Bras Dermatol. 2014;89(6):925–38.
Gunawan H, Achdiat PA, Hindritiani R, Essary ED, Ningtias LD, Siregar EP, et al. Various cutaneous tuberculosis with rare clinical manifestations: a case series. Int J Mycobacteriol. 2018;7(3):288–91.
Suraprasit P, Silpa-Archa N, Triwongwaranat D. Cutaneous miliary tuberculosis in a chronic kidney disease patient. Case Rep Dermatol. 2014;6(3):253–7.
Yodmalai S, Chiewchanvit S, Mahanupab P. Cutaneous military tuberculosis in a renal transplant patient: a case report and literature review. Southeast Asian J Trop Med Public Health. 2011;42(3):674–8.
Evans NS, Pritchett EN, Jones K, Doyle A, Chung CL, Allen HB, et al. Cutaneous gummatous tuberculosis in a kidney transplant patient. Cutis. 2019;103(2):E32–5.
Voigtländer T, Cornberg M, Gottlieb J, Welte T, Suerbaum S, Bange F-C. When a respiratory pathogen turns to the skin: cutaneous tuberculosis in a lung transplant patient. Ther Adv Respir Dis. 2015;9:260–2.
Agarwal P, Singh EM, Agarwal US, Meena R, Purohit S, Kumar S. The role of DNA polymerase chain reaction, culture and histopathology in the diagnosis of cutaneous tuberculosis. Int J Dermatol. 2017;56:1119–24.
Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VL. Cutaneous tuberculosis: diagnosis, histopathology and treatment—part II. An Bras Dermatol. 2014;89(4):545–55.
Costa LL, Veasey JV. Diagnosis of cutaneous tuberculosis (lymph node scrofuloderma) using the Xpert MTB/RIF method. An Bras Dermatol. 2021;96(1):82–4.
Epstein DJ, Subramanian AK. Prevention and management of tuberculosis in solid organ transplant recipients. Infect Dis Clin N Am. 2018;32(2):703–18.
Adu D, Evans DB, Millard PR, Calne RY, Shwe T, Jopling WH. Renal transplantation in leprosy. Br Med J. 1973;2:280–1.
WHO. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Wkly Epidemiol Rec. 2020;36(95):417–40.
Machado CM, Martins TC, Colturato I, et al. Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center. Rev Inst Med Trop S Paulo. 2009;51(6):309–24.
Aytekin S, Yasar S, Göktay F, et al. Lepromatous leprosy in a renal transplant recipient. Am J Transplant. 2017;17:2224–6.
Vieira AP, Trindade MAB, de Paula FJ, et al. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells? BMC Infect Dis. 2017;17(1):305.
Trindade MAB, Palermo ML, Pagliari C, et al. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature. Transpl Infect Dis. 2011;13(1):63–9.
Teruel JL, Liaño F, del Hoyo M, et al. Successful kidney transplantation in leprosy and transitory recurrence of the disease. Int J Lepr Other Mycobact Dis. 1985;53(3):410–1.
Shih H-C, Hung T-W, Lian J-D, Tsao S-M, Hsieh N-K, Yang J-H. Leprosy in a renal transplant recipient: a case report and literature review. J Dermatol. 2005;32(8):661–6.
Roselino AM, de Almeida AM, Foss NT, Lima VJ, Raspanti EO, Ferraz AS. Renal transplantation in leprosy patients. Int J Lepr Other Mycobact Dis. 1993;61(1):102–5.
Date A, John GT, Thomas PP, Jacob CK. Leprosy and renal transplantation. Lepr Rev. 1998;69(1):40–5.
Ducette K, Fishman JÁ. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38(10):1428–39.
Abad CL, Razonable RR. Non-tuberculous mycobacterial infections in solid organ transplant recipients: an update. J Clin Tuberc Other Mycobact Dis. 2016;4:1–8.
Morand J-J. Manifestations cutanéomuqueuses des mycobactéries environnementales (dont Mycobacterium ulcerans). In: Encyclopedie Médicale et Chirurgicale, vol. 1. Toulon: Elsevier; 2016. p. 1–10.
Asiedu K, Scherpbier R, Raviglione M, WHO. Buruli ulcer: Mycobacterium ulcerans infection. Paris, Tokyo: Association Française Raoul Follereau/The Nippon Foundation; 2000. p. 6. Available: https://apps.who.int/iris/bitstream/handle/10665/66164/WHO_CDS_CPE_GBUI_2000.1.pdf. Accessed 12/1/2021.
Assiri A, Euvrard S, Kanitakis J. Cutaneous Mycobacterium marinuma infection (fish tank granuloma) in renal transplant recipient: case report and literature review. Cureus. 2019;11(1):e6013. https://doi.org/10.7759/cureous.6013.
Henkle E, Winthrop K. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36(1):91–9.
Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis. 1993;16(4):463–71.
Zappe CH, Barlow D, Zappe H, Bolton IJ, Roditi D, Steyn LM. 16S rRNA sequence analysis of an isolate of Mycobacterium haemophilum from a heart transplant patient. J Med Microbiol. 1995;43(3):189–91.
Brix SR, Iking-Konert C, Stahl RA, Wenzel U. Disseminated Mycobacterium haemophilum infection in a renal transplant recipient. BMJ Case Rep. 2016;2016:bcr2016216042.
Pacholec M, Sami F, Newell K, El Atrouni W. Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient. J Clin Tuberc Other Mycobact Dis. 2020;21:100197.
Endzweig CH, Strauss E, Murphy F, Rao BK. A case of cutaneous Mycobacterium chelonae abscessus infection in a renal transplant patient. J Cutan Med Surg. 2001;5(1):28–32.
Lovric S, Becker JU, Kayser D, Wagner A, Haubitz M, Kielstein JT. Fish, flesh and a good red herring: a case of ascending upper limb infection in a renal transplant patient. Clin Nephrol. 2009;72(5):402–4.
Baisi A, Nosotti M, Chella B, Santambrogio L. Relapsing cutaneous Mycobacterium chelonae infection in a lung transplant patient. Transpl Int. 2005;18:1117–9.
Stelzmueller I, Dunst KM, Wiesmayr S, Zangerle R, Hengster P, Bonatti H. Emerg Infect Dis. 2005;11(2):352–3.
Malik S, Ghosh A, Husain S. Disseminated Mycobacteria chelonae infection in a kidney-pancreas transplant recipient: a case report and review of the literature. Saudi J Kidney Dis Transpl. 2016;27(6):1246–51.
Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis. 2014;16(1):76–83.
Copeland NK, Arora NS, Ferguson TM. Mycobacterium haemophilum masquerading as leprosy in a renal transplant recipient. Cas Rep Dermatol Med. 2013;2013:793127.
Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial. Int J Tuberc Lung Dis. 2009;13:1422–6.
Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc. 2010;42(8):3058–60.
Torres F, Hodges T, Zamora MR. Mycobacterium marinum infection in a lung transplant recipient. J Heart Lung Transplant. 2001;20(4):486–9.
Piersimoni C. Nontuberculous mycobacteria infection in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis. 2012;31(4):397–403.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tomimori, J., Florian, M.C. (2022). Mycobacterial Diseases. In: Tomimori, J., Oliveira, W.R.P.d., Ferrándiz-Pulido, C., Ogawa, M.M. (eds) Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients. Springer, Cham. https://doi.org/10.1007/978-3-031-13335-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-031-13335-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13334-3
Online ISBN: 978-3-031-13335-0
eBook Packages: MedicineMedicine (R0)